Breast Density Impact on Mammographic Screening for Breast Cancer Diagnosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Breast Density Impact on Mammographic Screening for Breast Cancer Diagnosis — Stella

Recruiting

Back to Breast Cancer Screening trials

Trial locations(1 site)

Italy

SSD Fisica Sanitaria - Ospedale Michele e Pietro Ferrero di Verduno (CN) - ASL CN2, Verduno, Italy/CN

Key details

Sponsor

Azienda Sanitaria Locale CN2 Alba-Bra

Enrollment target

~3,300 participants

Started

January 2026

Primary completion

June 2026

Age range

45 Years – 75 Years

Sex

Female only

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov